|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,015.60 |
3.29% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$60,644.10 |
2.89% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$52,229.73 |
2.49% |
| Waters Corporation |
WAT |
941848103 |
120 |
$47,278.80 |
2.25% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,885.07 |
2.18% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$45,191.52 |
2.15% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$45,022.85 |
2.14% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$44,795.83 |
2.13% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$44,648.48 |
2.13% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$44,418.04 |
2.12% |
| Steris Plc |
STE |
G8473T100 |
169 |
$44,496.01 |
2.12% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$44,396.69 |
2.11% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$44,165.00 |
2.10% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$44,036.00 |
2.10% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$44,135.91 |
2.10% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$43,999.01 |
2.10% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,798.04 |
2.09% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$43,515.67 |
2.07% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$42,964.90 |
2.05% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$42,960.17 |
2.05% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$42,437.80 |
2.02% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$42,281.11 |
2.01% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$42,301.60 |
2.01% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$42,058.59 |
2.00% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,242.08 |
1.96% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$41,193.00 |
1.96% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$41,202.64 |
1.96% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$40,831.09 |
1.94% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$40,495.84 |
1.93% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$40,575.86 |
1.93% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$40,492.78 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$40,141.43 |
1.91% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$39,635.81 |
1.89% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$39,602.56 |
1.89% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$38,807.78 |
1.85% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$38,561.11 |
1.84% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$38,692.15 |
1.84% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$37,577.14 |
1.79% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$37,291.34 |
1.78% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,283.38 |
1.78% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,268.60 |
1.77% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$36,860.76 |
1.76% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$36,860.25 |
1.76% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$36,954.62 |
1.76% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$36,816.82 |
1.75% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$35,602.44 |
1.70% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$35,687.14 |
1.70% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$35,264.78 |
1.68% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$33,269.27 |
1.58% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$32,280.11 |
1.54% |
| US Dollar |
$USD |
|
2,198 |
$2,198.35 |
0.10% |
| Japanese Yen |
$JPY |
|
102,506 |
$655.45 |
0.03% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|